Omega-3 fatty acid covered polypropylene mesh for abdominal wall hernia repair: A prospective analysis of 30 patients

2016-12-30T05-45-32Z
Source: Cukurova Medical Journal
Metin Yucel, Gurhan Bas, Fatih Basak, Adnan Ozpek, Ethem Unal, Ali Kilic.
Purpose: The main principle in abdominal wall hernia repair is achieving a tension free repair. To reduce adhesion risk caused by polypropylene mesh, meshes with anti-adhesive barrier have been introduced into clinical practice. The present study aimed to analyze postoperative outcomes in patients operated with omega-3 fatty acid covered polypropylene mesh for abdominal wall hernia repair. Materials and Methods: This study was prospective cohort conducted by examining the data of patients operated with omega-3 fatty acid covered polypropylene mesh between November 2010 and July 2015. The patients divided into two groups according to the operative technique (group 1: laparoscopic, group 2: open surgery). Omega-3 fatty acid covered polypropylene mesh was used as mesh (C-QURTM Mesh, Atrium Medical Corporation, Hudson, NH, USA). Primary parameters included complications, i.e., hernia recurrence, mesh adhesion, mesh infection and surgical site infection. Results: This study enrolled 30 patients (15 men, 15 women) with a mean age of 56.2±14.5 (range 17-83) years. Group 1 had eight patients (27%) who had laparoscopically repaired abdominal wall hernias, and group 2 included 22 (73%) patients who had abdominal wall hernias un-repairable by primary suture. Nine (30%) patients developed a complication. Age, sex and operative technique did not significantly affect complication rate. In patients who developed complication, defect size was significantly greater (p=0.009). One patient operated for adhesion-related complications died. The mean follow-up duration was 22.9 (range 3-53) months. Conclusion: The long-term effects of meshes with anti-adhesive barrier are unknown. It should be noted that this meshes have the potential to cause morbidity, serious health problems or even death.


from Scope via xlomafota13 on Inoreader http://ift.tt/2iMQhz8
via IFTTT